Serum concentrations of advanced glycation end products are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. - Aso,Y.; Inukai,T.; Tayama,K.; Takemura,Y. (Acta Diabetol, 2000)